BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 23320798)

  • 1. Do differences in clinical symptoms and referral patterns contribute to the gender gap in bladder cancer?
    Henning A; Wehrberger M; Madersbacher S; Pycha A; Martini T; Comploj E; Jeschke K; Tripolt C; Rauchenwald M
    BJU Int; 2013 Jul; 112(1):68-73. PubMed ID: 23320798
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative analysis of gender-related differences in symptoms and referral patterns prior to initial diagnosis of urothelial carcinoma of the bladder: a prospective cohort study.
    Aziz A; Madersbacher S; Otto W; Mayr R; Comploj E; Pycha A; Denzinger S; Fritsche HM; Burger M; Gierth M
    Urol Int; 2015; 94(1):37-44. PubMed ID: 25139297
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radical cystectomy for pT1 urothelial carcinoma of bladder not amenable to TURBT: Long-term results.
    Ma B; Li Y; Han S; Jiang X; Zhao Y; Guo J; Quan C; Niu Y
    Eur J Surg Oncol; 2019 Oct; 45(10):1993-1999. PubMed ID: 31327502
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gender discrepancies in bladder cancer: potential explanations.
    Viswambaram P; Hayne D
    Expert Rev Anticancer Ther; 2020 Oct; 20(10):841-849. PubMed ID: 32896196
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence and Survival of urothelial carcinoma of the urinary bladder in Norway 1981-2014.
    Andreassen BK; Aagnes B; Gislefoss R; Andreassen M; Wahlqvist R
    BMC Cancer; 2016 Oct; 16(1):799. PubMed ID: 27737647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does presence of squamous and glandular differentiation in urothelial carcinoma of the bladder at cystectomy portend poor prognosis? An intensive case-control analysis.
    Mitra AP; Bartsch CC; Bartsch G; Miranda G; Skinner EC; Daneshmand S
    Urol Oncol; 2014 Feb; 32(2):117-27. PubMed ID: 23477878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Accurate preoperative prediction of non-organ-confined bladder urothelial carcinoma at cystectomy.
    Green DA; Rink M; Hansen J; Cha EK; Robinson B; Tian Z; Chun FK; Tagawa S; Karakiewicz PI; Fisch M; Scherr DS; Shariat SF
    BJU Int; 2013 Mar; 111(3):404-11. PubMed ID: 22805163
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of immediate radical cystectomy in the treatment of patients with residual T1 bladder cancer on restaging transurethral resection.
    Sternberg IA; Keren Paz GE; Chen LY; Herr HW; Dalbagni G
    BJU Int; 2013 Jul; 112(1):54-9. PubMed ID: 23146082
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of gender on outcomes following radical cystectomy for urothelial carcinoma of the bladder: a critical analysis of 1,994 patients.
    Mitra AP; Skinner EC; Schuckman AK; Quinn DI; Dorff TB; Daneshmand S
    Urol Oncol; 2014 Jan; 32(1):52.e1-9. PubMed ID: 24239476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gender-specific differences in cancer-specific survival after radical cystectomy for patients with urothelial carcinoma of the urinary bladder in pathologic tumor stage T4a.
    May M; Bastian PJ; Brookman-May S; Fritsche HM; Tilki D; Otto W; Bolenz C; Gilfrich C; Trojan L; Herrmann E; Moritz R; Tiemann A; Müller SC; Ellinger J; Buchner A; Stief CG; Wieland WF; Höfner T; Hohenfellner M; Haferkamp A; Roigas J; Zacharias M; Nuhn P; Burger M
    Urol Oncol; 2013 Oct; 31(7):1141-7. PubMed ID: 22056404
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gender-specific outcomes of bladder cancer patients: a stage-specific analysis in a contemporary, homogenous radical cystectomy cohort.
    Soave A; Dahlem R; Hansen J; Weisbach L; Minner S; Engel O; Kluth LA; Chun FK; Shariat SF; Fisch M; Rink M
    Eur J Surg Oncol; 2015 Mar; 41(3):368-77. PubMed ID: 24674298
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of sex differences in cancer-specific survival and perioperative mortality following radical cystectomy: results of a large German multicenter study of nearly 2500 patients with urothelial carcinoma of the bladder.
    Otto W; May M; Fritsche HM; Dragun D; Aziz A; Gierth M; Trojan L; Herrmann E; Moritz R; Ellinger J; Tilki D; Buchner A; Höfner T; Brookman-May S; Nuhn P; Gilfrich C; Roigas J; Zacharias M; Denzinger S; Hohenfellner M; Haferkamp A; Müller SC; Kocot A; Riedmiller H; Wieland WF; Stief CG; Bastian PJ; Burger M
    Gend Med; 2012 Dec; 9(6):481-9. PubMed ID: 23217567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of histological variants on oncological outcomes of patients with urothelial carcinoma of the bladder treated with radical cystectomy.
    Xylinas E; Rink M; Robinson BD; Lotan Y; Babjuk M; Brisuda A; Green DA; Kluth LA; Pycha A; Fradet Y; Faison T; Lee RK; Karakiewicz PI; Zerbib M; Scherr DS; Shariat SF
    Eur J Cancer; 2013 May; 49(8):1889-97. PubMed ID: 23466126
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Nationwide, Population Based Analysis of Patients with Organ Confined, Muscle Invasive Bladder Cancer Not Receiving Curative Intent Therapy in Sweden from 1997 to 2014.
    Westergren DO; Gårdmark T; Lindhagen L; Chau A; Malmström PU
    J Urol; 2019 Nov; 202(5):905-912. PubMed ID: 31144594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contemporary gender-specific outcomes in Germany after radical cystectomy for bladder cancer.
    Schmid M; Shariat SF; Soave A; Engel O; Fisch M; Rink M
    Curr Urol Rep; 2014 Jun; 15(6):409. PubMed ID: 24756451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Time lag to diagnosis of bladder cancer--influence of psychosocial parameters and level of health-care provision.
    Månsson A; Anderson H; Colleen S
    Scand J Urol Nephrol; 1993; 27(3):363-9. PubMed ID: 8290917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The significance of lymphovascular invasion in transurethral resection of bladder tumour and cystectomy specimens on the survival of patients with urothelial bladder cancer.
    Streeper NM; Simons CM; Konety BR; Muirhead DM; Williams RD; O'Donnell MA; Joudi FN
    BJU Int; 2009 Feb; 103(4):475-9. PubMed ID: 18990174
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical variables which serve as predictors of cancer-specific survival among patients treated with radical cystectomy for transitional cell carcinoma of the bladder and prostate.
    Thrasher JB; Frazier HA; Robertson JE; Dodge RK; Paulson DF
    Cancer; 1994 Mar; 73(6):1708-15. PubMed ID: 8156499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk stratification for locoregional recurrence after radical cystectomy for urothelial carcinoma of the bladder.
    Novotny V; Froehner M; May M; Protzel C; Hergenröther K; Rink M; Chun FK; Fisch M; Roghmann F; Palisaar RJ; Noldus J; Gierth M; Fritsche HM; Burger M; Sikic D; Keck B; Wullich B; Nuhn P; Buchner A; Stief CG; Vallo S; Bartsch G; Haferkamp A; Bastian PJ; Hakenberg OW; Propping S; Aziz A
    World J Urol; 2015 Nov; 33(11):1753-61. PubMed ID: 25663359
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnosis and management of intradiverticular bladder tumours.
    Walker NF; Gan C; Olsburgh J; Khan MS
    Nat Rev Urol; 2014 Jul; 11(7):383-90. PubMed ID: 24934450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.